CHD EP March 2023 Abstracts

1. Use of implantable cardioverter-defibrillator in children supported with ventricular assist device: An analysis of data from the EUROMACS registry.

Schweiger M, Amodeo A, Vierecke J, Hussein H, Berger F, de By TMMH, Zimpfer D, Sliwka J, Davies B, Miera O, Meyns B.Artif Organs. 2023 Mar 1. doi: 10.1111/aor.14515. Online ahead of print.

PMID: 36855905

2. Ablation of Ventricular Preexcitation to Cure Preexcitation-Induced Dilated Cardiomyopathy in Infants: Diagnosis and Outcome.

Zhang Y, Jiang H, Cui J, Li MT, Zhou HM, Li XM.Circ Arrhythm Electrophysiol. 2023 Apr;16(4):e011569. doi: 10.1161/CIRCEP.122.011569. Epub 2023 Mar 9.

PMID: 36891895

3. Impaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated Cardiomyopathy.

Chun YW, Miyamoto M, Williams CH, Neitzel LR, Silver-Isenstadt M, Cadar AG, Fuller DT, Fong DC, Liu H, Lease R, Kim S, Katagiri M, Durbin MD, Wang KC, Feaster TK, Sheng CC, Neely MD, Sreenivasan U, Cortes-Gutierrez M, Finn AV, Schot R, Mancini GMS, Ament SA, Ess KC, Bowman AB, Han Z, Bichell DP, Su YR, Hong CC.Circulation. 2023 Apr 25;147(17):1291-1303. doi: 10.1161/CIRCULATIONAHA.122.060985. Epub 2023 Mar 27.

PMID: 36970983

4. Sudden cardiac death in childhood hypertrophic cardiomyopathy.

Thakkar K, Karajgi AR, Kallamvalappil AM, Avanthika C, Jhaveri S, Shandilya A, Anusheel, Al-Masri R.Dis Mon. 2023 Apr;69(4):101548. doi: 10.1016/j.disamonth.2023.101548. Epub 2023 Mar 15.

PMID: 36931945

5. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.

Xu X, Guo Y, Gao W, Huang M, Liu T, Li F.Eur J Pediatr. 2023 May;182(5):2265-2271. doi: 10.1007/s00431-023-04891-8. Epub 2023 Mar 4.

PMID: 36869903

6. Conduction system pacing in pediatric and congenital heart disease.

Chubb H, Mah D, Dubin AM, Moore J.Front Physiol. 2023 Mar 24;14:1154629. doi: 10.33 89/fphys.2023.1154629. eCollection 2023.PMID: 37035676 

7. Catheter ablation of coronary sinus accessory pathways in the young.

Müller MJ, Fischer O, Dieks J, Schneider HE, Paul T, Krause U.Heart Rhythm. 2023 Jun;20(6):891-899. doi: 10.1016/j.hrthm.2023.03.006. Epub 2023 Mar 8.

PMID: 36898470

8. Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease.

Dasgupta S, Shalhoub K, El-Assaad I, O’Leary E, Feins EN, Triedman JK, Walsh EP, Kheir JN, Dionne A.Heart Rhythm. 2023 Jul;20(7):1011-1017. doi: 10.1016/j.hrthm.2023.03.005. Epub 2023 Mar 8.

PMID: 36898471

9. New frontiers in taking care of children with heart rhythm disorders and pediatric electrophysiology publications.

Berul CI.Heart Rhythm. 2023 Jun;20(6):935-936. doi: 10.1016/j.hrthm.2023.03.014. Epub 2023 Mar 16.

PMID: 36933852

10. Sudden Cardiac Death Among Adolescents in the United Kingdom.

Finocchiaro G, Radaelli D, D’Errico S, Papadakis M, Behr ER, Sharma S, Westaby J, Sheppard MN.J Am Coll Cardiol. 2023 Mar 21;81(11):1007-1017. doi: 10.1016/j.jacc.2023.01.041.

PMID: 36922085

11. Sudden Cardiac Death in Adolescents: Allowing the Dead to Speak.

DeWitt E, Etheridge SP.J Am Coll Cardiol. 2023 Mar 21;81(11):1018-1020. doi: 10.1016/j.jacc.2023.01.023.

PMID: 36922086 

12. Quality of life of children and young adults with and without cardiovascular implantable electronic devices during the COVID-19 pandemic.

Needleman JS, Zhu C, Kean AC.Pacing Clin Electrophysiol. 2023 Apr;46(4):285-291. doi: 10.1111/pace.14677. Epub 2023 Mar 12.

PMID: 36788646

13. Long-term follow-up in preschool children after radiofrequency catheter ablation of arrhythmias.

Svintsova LI, Krivolapov SN, Dzhaffarova OY, Plotnikova IV.J Arrhythm. 2023 Mar 10;39(3):405-411. doi: 10.1002/joa3.12827. eCollection 2023 Jun.

PMID: 37324759

14. How to perform catheter ablation of atrial tachyarrhythmia after the Fontan operation.

Kamp A, Moore JP, Khairy P.Heart Rhythm. 2023 Jul;20(7):1048-1054. doi: 10.1016/j.hrthm.2023.03.023. Epub 2023 Mar 22.

PMID: 3696

15. Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease.

Moore JP, de Groot NMS, O’Connor M, Cortez D, Su J, Burrows A, Shannon KM, O’Leary ET, Shah M, Khairy P, Atallah J, Wong T, Lloyd MS, Taverne YJHJ, Dubin AM, Nielsen JC, Evertz R, Czosek RJ, Madhavan M, Chang PM, Aydin A, Cano Ó

16. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.

Liu AY, Charron J, Fugaro D, Spoolstra S, Kaplan R, Lohrmann G, Gao X, Gay H, Passman R, Kim S, Lin AC, Chicos A, Arora R, Patil K, Pfenniger A, Knight BP, Verma N.J Cardiovasc Electrophysiol. 2023 Mar;34(3):502-506. doi: 10.1111/jce.15819. Epub 2023 Feb 22.

PMID: 36640424

17. Incidence and Clinical Predictors of Early and Late Complications of Implantable Cardioverter-Defibrillators in Adults With Congenital Heart Disease.

Albertini L, Kawada S, Nair K, Harris L.Can J Cardiol. 2023 Mar;39(3):236-245. doi: 10.1016/j.cjca.2022.12.012. Epub 2022 Dec 22.

PMID: 36565849

18. Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes.

Wang W, Gasperetti A, Sears SF, Tichnell C, Murray B, Tandri H, James CA, Calkins H.JACC Clin Electrophysiol. 2023 Mar;9(3):394-402. doi: 10.1016/j.jacep.2022.09.020. Epub 2022 Oct 31.

PMID: 36328892